BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 18361180)

  • 1. [Bisphosphonate-induced osteonecrosis of the jaws--a guide to diagnosis, therapy and prevention of BON in dental practice].
    Dannemann C; Grätz KW; Zwahlen RA
    Schweiz Monatsschr Zahnmed; 2008; 118(2):113-23. PubMed ID: 18361180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Bisphosphonate associated osteonecrosis of the jaws--the role of the dentist in prevention and early diagnosis].
    Yarom N; Rachima H; Yahalom R
    Refuat Hapeh Vehashinayim (1993); 2006 Apr; 23(2):39-42, 67. PubMed ID: 16886875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bisphosphonates and osteonecrosis of the jaws.
    Mariotti A
    J Dent Educ; 2008 Aug; 72(8):919-29. PubMed ID: 18676801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bisphosphonates and osteonecrosis of the jaws: science and rationale.
    Gutta R; Louis PJ
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Aug; 104(2):186-93. PubMed ID: 17448709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A review of bisphosphonate-associated osteonecrosis of the jaws and its management.
    Lam DK; Sándor GK; Holmes HI; Evans AW; Clokie CM
    J Can Dent Assoc; 2007 Jun; 73(5):417-22. PubMed ID: 17555652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bisphosphonate-related osteonecrosis of the jaw: diagnosis, prevention, and management.
    Ruggiero SL; Mehrotra B
    Annu Rev Med; 2009; 60():85-96. PubMed ID: 18928335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Osteonecrosis of the jaws: a secondary effect of bisphosphonates].
    Schortinghuis J; Meijndert L; De Visscher JG; Witjes MJ
    Rev Belge Med Dent (1984); 2007; 62(4):168-75. PubMed ID: 18506991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of patients on bisphosphonates and prevention of bisphosphonate-related osteonecrosis of the jaw.
    Chu V; ;
    Hawaii Dent J; 2008; 39(5):9-12; quiz 17. PubMed ID: 19189512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws--2009 update.
    Ruggiero SL; Dodson TB; Assael LA; Landesberg R; Marx RE; Mehrotra B;
    J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):2-12. PubMed ID: 19371809
    [No Abstract]   [Full Text] [Related]  

  • 10. Canadian consensus practice guidelines for bisphosphonate associated osteonecrosis of the jaw.
    Khan AA; Sándor GK; Dore E; Morrison AD; Alsahli M; Amin F; Peters E; Hanley DA; Chaudry SR; Dempster DW; Glorieux FH; Neville AJ; Talwar RM; Clokie CM; Al Mardini M; Paul T; Khosla S; Josse RG; Sutherland S; Lam DK; Carmichael RP; Blanas N; Kendler D; Petak S; St-Marie LG; Brown J; Evans AW; Rios L; Compston JE;
    J Rheumatol; 2008 Jul; 35(7):1391-7. PubMed ID: 18528958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics.
    Pazianas M; Miller P; Blumentals WA; Bernal M; Kothawala P
    Clin Ther; 2007 Aug; 29(8):1548-58. PubMed ID: 17919538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bisphosphonate-induced osteonecrosis of the jaw: a medical enigma?
    Siddiqi A; Payne AG; Zafar S
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Sep; 108(3):e1-8. PubMed ID: 19570696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteonecrosis of the jaws and bisphosphonates.
    Woo SB; Kalmar JR
    Alpha Omegan; 2007; 100(4):194-202. PubMed ID: 18335818
    [No Abstract]   [Full Text] [Related]  

  • 14. Bisphosphonate osteonecrosis of the jaw--a literature review of UK policies versus international policies on bisphosphonates, risk factors and prevention.
    Patel V; McLeod NM; Rogers SN; Brennan PA
    Br J Oral Maxillofac Surg; 2011 Jun; 49(4):251-7. PubMed ID: 20605289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Bisphosphonates (BP) and osteonecrosis of the jaws; continuous treatment with Bisphosphonates should be considered].
    Mawatari T
    Clin Calcium; 2010 Nov; 20(11):1743-7. PubMed ID: 21066910
    [No Abstract]   [Full Text] [Related]  

  • 16. [Bisphosphonates and osteonecrosis of the jaws].
    Urade M
    Clin Calcium; 2007 Feb; 17(2):241-8. PubMed ID: 17272882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent recommendations on bisphosphonate-associated osteonecrosis of the jaw.
    Arrain Y; Masud T
    Dent Update; 2008 May; 35(4):238-40, 242. PubMed ID: 18557500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bisphosphonate-related osteochemonecrosis of the jaws.
    Hegarty A; Georgakopolou E; Porter S
    Br J Hosp Med (Lond); 2008 Mar; 69(3):158-62. PubMed ID: 18422225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bisphosphonate-related osteonecrosis of the jaw: an overview.
    Ruggiero SL
    Ann N Y Acad Sci; 2011 Feb; 1218():38-46. PubMed ID: 20946580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bisphosphonate-related osteonecrosis of the jaw: background and guidelines for diagnosis, staging and management.
    Ruggiero SL; Fantasia J; Carlson E
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Oct; 102(4):433-41. PubMed ID: 16997108
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.